Sale of unaffected batches of Medicube capsule cream can resume: HSA
Minute amounts of the banned Sudan IV dye were found in two samples of Medicube PDRN Pink Collagen Capsule Cream sold by Venus Beauty.
The Health Sciences Authority (HSA) in Singapore has announced that sales of unaffected batches of Medicube PDRN Pink Collagen Capsule Cream may resume following tests that detected no traces of the banned Sudan IV dye. The HSA had previously directed three companies - APR SG, Venus Beauty, and Rirora International - to halt sales while samples were tested.
Sudan Red dyes, including Sudan IV, are prohibited for use in cosmetic products due to their carcinogenic and genotoxic properties. HSA found minute amounts of Sudan IV in two samples sold by Venus Beauty, and subsequently ordered a recall of those affected batches. The other two companies may resume sales of their unaffected batches.
Consumers are advised not to use the affected products and should contact sellers for refunds if they have concerns. The HSA will continue monitoring the situation and companies must ensure all future batches are tested for Sudan IV before local sale.
Written by urgent.news from CNA - Singapore's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Sale of unaffected batches of Medicube capsule cream can resume: HSA channelnewsasia.com
